Volume 78, Issue 2 pp. 117-122
Original Article
Free Access

Small FVIII gene rearrangements in 18 hemophilia A patients: Five novel mutations

Maria Patrizia Bicocchi

Maria Patrizia Bicocchi

Department of Hematology and Oncology, Thrombosis and Hemostasis Unit, Giannina Gaslini Institute, Genova, Italy

Search for more papers by this author
Mirella Pasino

Corresponding Author

Mirella Pasino

Department of Hematology and Oncology, Thrombosis and Hemostasis Unit, Giannina Gaslini Institute, Genova, Italy

Department of Hematology and Oncology, Thrombosis and Hemostasis Unit, G. Gaslini Institute, Largo G. Gaslini n. 5, 16147 Genova, ItalySearch for more papers by this author
Tiziana Lanza

Tiziana Lanza

Department of Hematology and Oncology, Thrombosis and Hemostasis Unit, Giannina Gaslini Institute, Genova, Italy

Search for more papers by this author
Federico Bottini

Federico Bottini

Department of Hematology and Oncology, Thrombosis and Hemostasis Unit, Giannina Gaslini Institute, Genova, Italy

Search for more papers by this author
Angelo Claudio Molinari

Angelo Claudio Molinari

Department of Hematology and Oncology, Thrombosis and Hemostasis Unit, Giannina Gaslini Institute, Genova, Italy

Search for more papers by this author
Daniela Caprino

Daniela Caprino

Department of Hematology and Oncology, Thrombosis and Hemostasis Unit, Giannina Gaslini Institute, Genova, Italy

Search for more papers by this author
Camillo Rosano

Camillo Rosano

X-Ray Structural Biology Unit (B2), Advanced Biotechnology Center (CBA), Genova, Italy

Search for more papers by this author
Maura Acquila

Maura Acquila

Department of Hematology and Oncology, Thrombosis and Hemostasis Unit, Giannina Gaslini Institute, Genova, Italy

Search for more papers by this author
First published: 28 January 2005
Citations: 2

Abstract

Hemophilia A (HA) is a disorder caused by mutations of the FVIII gene, which is located on the tip of the long arm of the X chromosome. In a cohort of 18 unrelated Italian patients affected with HA of varying severity, we performed mutational screening of the gene by denaturing high-performance liquid chromatography (DHPLC) and direct sequencing of abnormal peaks. We identified five novel mutations and 9 previously reported DNA alterations. Two of the 9 previously reported alterations were each common to 3 unrelated patients. Six different mutations were characterized as missense alterations, while 8 were non-missense mutations. Among the new gene alterations, one created a stop codon, one consisted of an out-of frame deletion, and one was a splice-site mutation. The last two were missense alterations. In an attempt to better understand the causative effect of the mutations and the clinical variability of the patients, we investigated the consequences of each missense mutation and visualized the effect of the amino acid change on structural FVIII models. Am. J. Hematol. 78:117–122, 2005. © 2005 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.